Results 91 to 100 of about 15,817 (194)

Updates in the treatment of chronic hepatitis B [PDF]

, 2008
published_or_final_versio
Fung, J, Lai, CL, Yuen, MF
core  

Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy

Virology Journal
Background No study has comparing hepatitis B virus (HBV) relapse rates among patients with both cancer and hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) who completed anti-viral prophylaxis for chemotherapy and then stopped taking ...
Hsin-Wei Fang, Po-Lin Tseng, Tsung-Hui Hu, Jing-Houng Wang, Chao-Hung Hung, Sheng-Nan Lu, Chien-Hung Chen   +6 more
doaj   +1 more source

Management of Antiviral Resistance in Chronic Hepatitis B

Gut and Liver, 2017
The primary goal of therapy for chronic hepatitis B (CHB) is to prevent liver disease progression. Hepatitis B surface antigen (HBsAg) seroclearance or seroconversion is regarded as an optimal endpoint to discontinue treatment.
Young-Suk Lim
doaj   +1 more source

Hepatitis B virus with primary resistance to adefovir [11] [PDF]

, 2006
Correspondencepublished_or_final_versio
Chang, TT, Lai, CL
core   +1 more source

Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients [PDF]

, 2008
Background To investigate dynamic fluctuations of serum viral load and peripheral T-lymphocyte subpopulations of chronic hepatitis B patients and their correlation during entecavir therapy. Methods Fifty-five patients received entecavir 0.5 mg/d therapy.
Jing You, Hutcha Sriplung, Alan Geater, Virasakdi Chongsuvivatwong, Lin Zhuang, Yun-Li Li, Hua Lei, Jun Liu, Hong-Ying Chen, Bao-Zhang Tang, Jun-Hua Huang, JN Stoop, TI Michalak, N Tulek, U Khettry, TF Baumert, A Bertoletti, DX Liu, JN Stoop, O Franzese, C Boni, C Boni, C Boni, JL Dienstag, HL Tillmann, A Rivkin, RG Gish, EB Keeffe, TT Chang, CL Lai, G Yao, M Sherman, AS Lok, N Leung, RG Gish, JN Stoop, GK Lau, Y Kondo, E Mizukoshi   +38 more
core   +2 more sources

Severe Acute Hepatitis B Treated with Entecavir

Mediterranean Journal of Hematology and Infectious Diseases, 2011
Hepatitis B virus (HBV) infection constitutes a serious global health problem. Nowadays there are divergent data regarding the use of antiviral drugs to treat acute hepatitis B.
Giuseppe Vittorio Luigi De Socio, Alessio Sgrelli, Andrea Tosti, Franco Baldelli   +3 more
doaj   +1 more source

Impacto de la utilización de hígados de donantes anti-HBc positivo en pacientes trasplantados por hepatitis B [PDF]

, 2011
El nostre objectiu és avaluar l'impacte de la utilització de fetges de donants anti-HBc positius en pacients trasplantats per hepatitis B, els quals van ser revisats de manera retrospectiva.
García Eliz, Marcia, Prieto Castillo, Martín, Universitat Autònoma de Barcelona. Departament de Medicina, Universitat Autònoma de Barcelona. Facultat de Medicina, Vargas Blasco, Víctor   +4 more
core  

Antivirais incorporados no Brasil para hepatite B cronica: analise de custo-efetividade

Revista de Saúde Pública, 2013
OBJETIVO Avaliar o custo-efetividade de diferentes tratamentos medicamentosos para hepatite B crônica entre pacientes adultos. MÉTODOS Utilizando modelo de Markov, construiu-se coorte hipotética de 40 anos para pacientes HBeAg-positivo ou HBeAg ...
Gustavo Laine Araujo de Oliveira, Alessandra Maciel Almeida, Anderson Lourenco da Silva, Cristina Mariano Ruas Brandao, Eli Iola Gurgel Andrade, Mariangela Leal Cherchiglia, Francisco de Assis Acurcio   +6 more
doaj   +1 more source

Removal of the Active Pharmaceutical Substance Entecavir from Water via the Fenton Reaction or Action by the Cyanobacterium Microcystis novacekii

Toxics
Entecavir (ETV) is an antiviral used to treat chronic infection caused by the hepatitis B virus, which affects approximately 250 million people worldwide.
Cléssius Ribeiro de Souza, Gabriel Souza-Silva, Carolina Paula de Souza Moreira, Olívia Maria S. R. Vasconcelos, Kenia Pedrosa Nunes, Cíntia Aparecida J. Pereira, Marcos Paulo Gomes Mol, Micheline Rosa Silveira   +7 more
doaj   +1 more source

Entecavir-Associated Thrombocytopenia: A Case Report and Review of the Pathophysiology, Diagnosis, and Treatment of a Rare but Reversible Cause of Thrombocytopenia

Case Reports in Hematology, 2019
Drug-associated thrombocytopenia is often unrecognized. We report a 76-year-old female with lymphoma who presented with easy bruising and oral bleeding. She had undergone screening for hepatitis B virus (HBV) prior to starting rituximab and was found to ...
Binoy Yohannan, Dai Chu N. Luu, Mark Feldman   +2 more
doaj   +1 more source